2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function

Mol Med. 2021 Jul 16;27(1):79. doi: 10.1186/s10020-021-00334-y.

Abstract

Background: High mobility group box 1 protein (HMGB1) is an alarmin following its release by immune cells upon cellular activation or stress. High levels of extracellular HMGB1 play a critical role in impairing the clearance of invading pulmonary pathogens and dying neutrophils in the injured lungs of cystic fibrosis (CF) and acute respiratory distress syndrome (ARDS). A heparin derivative, 2-O, 3-O desulfated heparin (ODSH), has been shown to inhibit HMGB1 release from a macrophage cell line and is efficacious in increasing bacterial clearance in a mouse model of pneumonia. Thus, we hypothesized that ODSH can attenuate the bacterial burden and inflammatory lung injury in CF and we conducted experiments to determine the underlying mechanisms.

Methods: We determined the effects of ODSH on lung injury produced by Pseudomonas aeruginosa (PA) infection in CF mice with the transmembrane conductance regulator gene knockout (CFTR-/-). Mice were given ODSH or normal saline intraperitoneally, followed by the determination of the bacterial load and lung injury in the airways and lung tissues. ODSH binding to HMGB1 was determined using surface plasmon resonance and in silico docking analysis of the interaction of the pentasaccharide form of ODSH with HMGB1.

Results: CF mice given 25 mg/kg i.p. of ODSH had significantly lower PA-induced lung injury compared to mice given vehicle alone. The CF mice infected with PA had decreased levels of nitric oxide (NO), increased levels of airway HMGB1 and HMGB1-impaired macrophage phagocytic function. ODSH partially attenuated the PA-induced alteration in the levels of NO and airway HMGB1 in CF mice. In addition, ODSH reversed HMGB1-impaired macrophage phagocytic function. These effects of ODSH subsequently decreased the bacterial burden in the CF lungs. In a surface plasmon resonance assay, ODSH interacted with HMGB1 with high affinity (KD = 3.89 × 10-8 M) and induced conformational changes that may decrease HMGB1's binding to its membrane receptors, thus attenuating HMGB1-induced macrophage dysfunction.

Conclusions: The results suggest that ODSH can significantly decrease bacterial infection-induced lung injury in CF mice by decreasing both HMGB1-mediated impairment of macrophage function and the interaction of HMGB1 with membrane receptors. Thus, ODSH could represent a novel approach for treating CF and ARDS patients that have HMGB1-mediated lung injury.

Keywords: Cystic fibrosis; HMGB1; Macrophage functions; NO; ODSH; Phagocytosis; Pulmonary infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Load
  • Biomarkers
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / metabolism*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis Transmembrane Conductance Regulator / metabolism
  • Disease Models, Animal
  • Disease Susceptibility
  • HMGB1 Protein / chemistry
  • HMGB1 Protein / genetics*
  • HMGB1 Protein / metabolism
  • Heparin / analogs & derivatives*
  • Heparin / chemistry
  • Heparin / metabolism
  • Host-Pathogen Interactions / genetics
  • Host-Pathogen Interactions / immunology
  • Immunohistochemistry
  • Macrophages / immunology*
  • Macrophages / metabolism*
  • Male
  • Mice
  • Mice, Knockout
  • Models, Molecular
  • Nitric Oxide / metabolism
  • Phagocytosis / immunology
  • Pneumonia, Bacterial / etiology*
  • Pneumonia, Bacterial / metabolism*
  • Pneumonia, Bacterial / pathology
  • Protein Binding
  • RAW 264.7 Cells
  • Structure-Activity Relationship

Substances

  • Biomarkers
  • HMGB1 Protein
  • heparin, O-desulfated
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Nitric Oxide
  • Heparin